Publications by authors named "Thomas Baumert"

Claim this Profile
C
Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis.
Fabio Del Zompo, Emilie Crouchet, Tessa Ostyn, Zeina Nehme, Mélissa Messé, Thomas F Baumert

J Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Human Liver Chimeric Mice to Study Hepatitis C Virus Antibody Escape: Implications for Vaccine Development.
Che C Colpitts, Thomas F Baumert

Cell Mol Gastroenterol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting peroxiredoxin 2 prevents hepatocarcinogenesis in metabolic liver disease models.
Emilie Crouchet, Eugénie Schaeffer, Marine A Oudot, Julien Moehlin, Cloé Gadenne, Thomas F Baumert

J Clin Invest· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excited State Assignment and State-Resolved Photoelectron Circular Dichroism in Chalcogen-Substituted Fenchones.
Sudheendran Vasudevan, Steffen M Giesen, Simon T Ranecky, Lutz Marder, Igor Vidanović, Thomas Baumert

Chemphyschem· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Velocity map imaging spectrometer optimized for reduction of background electrons from scattered UV light.
Nicolas Ladda, Fabian Westmeier, Sagnik Das, Wilfried Dreher, Simon T Ranecky, Thomas Baumert

Rev Sci Instrum· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving risk stratification and detection of early HCC using ultrasound-based deep learning models.
Jérémy Dana, Adrien Meyer, Anita Paisant, Agnès Rode, Riccardo Sartoris, Thomas F Baumert

JHEP Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perturbation of the circadian clock in chronic diseases involving organ fibrosis.
Atish Mukherji, Pierre-Louis Tharaux, David W Ray, Thomas F Baumert

J Clin Invest· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fine-tuning of hepatitis C virus immune evasion through hypervariable region 1 insertions.
Che C Colpitts, Thomas F Baumert

Hepatology· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B virus-infected hepatocytes promote the secretion of collagen VI to the extracellular matrix.
Alessia Virzì, Zakaria Boulahtouf, Julien Moehlin, Lea Girard, Laura Meiss-Heydmann, Thomas F Baumert

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time for arginine methylation: PRMT5 inhibition to advance cholangiocarcinoma treatment.
Romain Désert, Lipika Goyal, Thomas F Baumert

Gut· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
7
7-T MRI-based surrogate for histopathology examination of liver fibrosis.
Jérémy Dana, Antonin Fattori, Chrystelle Po, Aurélie Beaufrère, Valérie Vilgrain, Thomas F Baumert

Eur Radiol Exp· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control of circular dichroism in ion yield of 3-methyl cyclopentanone with femtosecond laser pulses.
Sagnik Das, Jayanta Ghosh, Sudheendran Vasudevan, Simon T Ranecky, Tonio Rosen, Thomas Baumert

Phys Chem Chem Phys· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mammary tumor development induces perturbation of liver glucose metabolism with inflammation and fibrosis.
Anouk Charlot, Anthony Bringolf, Joris Mallard, Amélie Jaulin, Emilie Crouchet, Thomas F Baumert

Am J Physiol Endocrinol Metab· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling the genetic susceptibility to HBV-related liver cancer: The role of virus-host immune interactions.
Pierre Tonnerre, Yujin Hoshida, Thomas F Baumert

Hepatology· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The circadian clock: a new therapeutic target for liver fibrosis].
Émilie Crouchet, Catherine Schuster, Thomas F Baumert

Med Sci (Paris)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models.
Romain Desert, Fabio Gianonne, Antonio Saviano, Yujin Hoshida, Mathias Heikenwälder, Thomas F Baumert

Gut Liver· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A patient-derived HCC spheroid system to model the tumor microenvironment and treatment response.
Emilie Crouchet, Nuno Almeida, Sarah C Durand, Marie Parnot, Marine A Oudot, Thomas F Baumert

JHEP Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development.
Anne T Schneider, Christiane Koppe, Emilie Crouchet, Aristeidis Papargyriou, Michael T Singer, Thomas F Baumert

Nat Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the liver clock improves fibrosis by restoring TGF-β signaling.
Emilie Crouchet, Mayssa Dachraoui, Frank Jühling, Natascha Roehlen, Marine A Oudot, Thomas F Baumert

J Hepatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic.
Hiroyuki Suzuki, Naoto Fujiwara, Amit G Singal, Thomas F Baumert, Raymond T Chung

Hepatology· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver disease.
Armando Andres Roca Suarez, Frank Jühling, Julien Moehlin, Laurent Mailly, Alessia Virzì, Thomas F Baumert

eGastroenterology· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulation and entry inhibition: selgantolimod's double punch against hepatitis B virus.
Thomas Baumert, Melanie Urbanek-Quaing, Markus Cornberg

Gut· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAM-A-dependent HBV core aggregation induces apoptosis through ANXA1.
Valerio Taverniti, Laura Meiss-Heydmann, Cloé Gadenne, Hannah Vanrusselt, Dieudonné Buh Kum, Thomas F Baumert

JHEP Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of genetic alterations on long-term outcomes in resectable intrahepatic cholangiocarcinoma: meta-analysis.
Fabio Giannone, Fabio Del Zompo, Antonio Saviano, Erwan Pencreach, Catherine Schuster, Thomas F Baumert

Br J Surg· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection.
Atish Mukherji, Frank Jühling, Yogy Simanjuntak, Emilie Crouchet, Fabio Del Zompo, Thomas F Baumert

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis